Ultimately, our analysis demonstrated that PSMD1 and PSMD3 mRNA and protein were markedly upregulated in numerous different cancers, which correlated with a worse OS, indicating they may serve as novel prognostic biomarkers in cancer diagnosis and therapy response. Here, PSMD3 is linked to cancer.